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Abstract
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Previous data has shown that adenylyl cyclase type 6 (AC6) is expressed principally in lipid rafts or
caveolae of cardiac myocytes and other cell types while certain other isoforms of AC are excluded
from these microdomains. The mechanism by which AC6 is localized to lipid rafts or caveolae is
unknown. In this study, we show AC6 is localized in lipid rafts of COS-7 cells (expressing caveolin-1)
and in HEK-293 cells or cardiac fibroblasts isolated from caveolin-1 knock-out mice (both of which
lack prototypical caveolins). To determine the region of AC6 that confers raft localization, we
independently expressed each of the major intracellular domains, the N-terminus, C1 and C2
domains, and examined their localization with various approaches. The N-terminus did not associate
with lipid rafts or caveolae of either COS-7 or HEK-293 cells nor did it immunoprecipitate with
caveolin-1 when expressed in COS-7 cells. By contrast, the C1 and C2 domains each associated with
lipid rafts to varying degrees and was present in caveolin-1 immunoprecipitates. There were no
differences in the pattern of localization of either the C1 or C2 domains between COS-7 and HEK-293
cells. Further dissection of the C1 domain into four individual proteins indicated that the N-terminal
half of this domain is responsible for its raft localization. To probe for a role of a putative
palmitoylation motif in the C-terminal portion of the C2 domain, we expressed various truncated
forms of AC6 lacking most or all of the C-terminal 41 amino acids. These truncated AC6 proteins
were not altered in terms of their localization in lipid rafts or their catalytic activity, implying that
this C-terminal region is not required for lipid raft targeting of AC6. We conclude that while the C1
domain may be most important, both the C1 and C2 domains of AC6 play a role in targeting AC6 to
lipid rafts.
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INTRODUCTION
It has recently been documented that GPCR’s and their associated signaling components such
as AC isoforms are not randomly dispersed throughout the plasma membrane [1,2]. Lipid rafts
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are rich in cholesterol and sphingolipids, and they display a high concentration of signaling
proteins, including G protein-coupled receptors (GPCR’s), G-proteins, and effectors such as
ion channels and adenylyl cyclases (AC’s)[1,3,4]. The caveolin/lipid raft signaling hypothesis
proposes that compartmentation of signaling molecules in these microdomains provides a
mechanism for temporal and spatial signal transduction and cross-talk among signaling
pathways [5,6]. However, by no means are all membrane-associated signaling proteins located
in lipid rafts [3,7]. Understanding how this differential plasma membrane localization occurs
may illuminate the significance of raft versus non-raft targeting of GPCR signaling
components.
Adenylyl cyclases are a key effector component of transmembrane signaling pathways that are
both positively and negatively regulated by the activity of heterotrimeric G proteins and
GPCR’s. There are nine different mammalian isoforms of AC’s and each isoform displays
distinct lipid raft or non-raft localization [1,8,9]. AC3, AC5, AC6 and AC8 are expressed in
lipid rafts of various cell types while the other isoforms of AC are not [10–15]. The distinct
localization of the raft-associated AC isoforms facilitates regulation of theses enzymes by
specific receptors and other regulatory influences such as calcium and contributes to the
compartmentalization of cAMP signaling [9,16,17]. However, only relatively recently has it
begun to be understood how a combination of protein–protein and protein–lipid interactions
contributes to the manifestation GPCR signaling compartmentalization in lipid raft domains.
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The nine membrane-bound AC’s share a common secondary structure comprising an
intracellular N-terminus, two cassettes of six transmembrane domains in tandem separated by
a cytoplasmic loop, termed the C1 domain, and a C-terminal cytoplasmic C2 domain. The
ATP-binding C1a and C2a domains are the most conserved regions between AC isoforms, and
their interaction forms the catalytic core [18,19]. The transmembrane domains are not essential
for catalytic activity because the C1a and C2a domains can be overexpressed separately in
vitro to form a Gsα- and forskolin-stimulable enzyme [20]. However, by their association, the
transmembrane domains have a crucial role in increasing the relative concentrations of their
attached catalytic domains so that they readily associate to form the catalytic core [21]. The
transmembrane spanning domains have also been suggested to be important in the regulation
of protein assembly and membrane trafficking of AC6 [22]. Recent kinetic investigations have
shown that dimerization is an important feature of G-protein regulation of AC. AC5 undergoes
a cooperative activation by Gsα that is consistent with Gsα binding to an AC5 dimer [23] and
AC2-AC5 heterodimers are more sensitive to G and forskolin than either isoform alone [24].
Other studies indicate that AC6, a homologue of AC5, also forms homodimers, as demonstrated
by the co-immunoprecipitation of two differently epitope-tagged forms of AC6 [25]. In the
case of AC6, dimerization was suggested to occur through intermolecular interactions between
the first transmembrane cassettes since the co-expression of the first transmembrane cassette
of AC6 not only co-immunoprecipitated but also reduced the plasma membrane expression
and activity of full-length AC6.
The transmembrane regions of GPCR’s and other membrane proteins, which are embedded in
the lipid bilayer, can dictate domain localization by interacting with the lipid and/or protein
components of rafts/caveolae. In particular, cholesterol specifically enriched in lipid
microdomains has attracted attention as a possible determinant of GPCR localization in lipid
rafts. The intracellular loops and carboxyl- terminal tail may all be involved in receptor
targeting to lipid rafts by means of different addressing signals: fatty acylation and proteinprotein interactions. Crossthwaite et. al. investigated the regions of AC that dictate lipid raft
localization by expressing various chimeric combinations of AC5 (a lipid raft-localized
isoform) and AC7 (a non-raft localized isoform [26]. These investigators concluded that the
C1 and the C2 domains were critical for lipid raft localization of AC5 and that the membranespanning domains have no role in this localization.
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In the present study, we sought to identify the structural elements of AC6 that determine its
localization to lipid rafts. We generated constructs corresponding to each intracellular segments
of the raft-targeted AC6 and studied their localization properties when expressed in COS-7
cells. Detergent- and non detergent-based methods for raft isolation, combined with
immunoprecipitations and confocal microscopic analysis, were used to confirm the cellular
localization of the expressed proteins. Our results indicate that the targeting of AC6 to lipid
raft depends only on the C1 and C2 cytosolic domains and is independent of the N terminal
domain and the extreme C-terminal tail. Our studies also show that caveolins are not required
for lipid raft localization of AC6. These studies will allow more detailed analysis of AC6 that
can determine the mechanism by which this protein, and likely others, localize to lipid rafts.

EXPERIMENTAL
Materials and cell culture
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Primary antibodies for AC5/6 were obtained from Santa Cruz Biotechnology. Primary antibody
for FLAG was obtained from Sigma. Primary antibody for caveolin-1was obtained from BD/
Transduction Laboratories. S-tag HRP-conjugated and anti-His antibody were obtained from
Novagen. All other chemicals and reagents were obtained from Sigma Aldrich. COS-7 and
HEK-293 cells were obtained from ATCC and were maintained in minimum essential medium
(MEM) supplemented with 10% horse serum and penicillin/streptomycin in a 37°C incubator
with 5% CO2. Cardiac fibroblasts were isolated from wild-type or caveolain-1 knockout mice
using a method adapted from Liu et al [27]. Briefly, hearts were rapidly excised and then
minced, pooled, and placed in a collagenase/pancreatin digestion solution. After five sequential
digestions, the fibroblasts were pelleted and resuspended in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with penicillin, streptomycin, fungizone, and 10% fetal
bovine serum (FBS, Atlanta Biologicals). After a 30-min period of attachment to uncoated
culture plates, cells that were weakly attached or unattached were rinsed free and discarded.
Cells were then cultured for two to four days. The purity of mouse cardiac fibroblast cultures
was greater than 95% as determined by positive staining for vimentin and negative staining
for smooth muscle actin and von Willebrand factor, as previously described [13]. All animals
were treated according to the principles of laboratory animal care (NIH publication No. 85-23,
revised 1985) and applicable US law.
Construction and expression of AC6 wild-type and truncation mutants
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We generated WT Flag-AC6 using pCDNA3.1-AC6 as a initial template. PCR fragments were
and then cloned into pEGFP-N1 vector, which had been digested with identical enzymes.
Positive clones were sequenced to verify the right open reading frame and the desired mutation.
Truncation mutants were fused with the FLAG epitope. We constructed the following protein
fragments of human AC6: N-terminus: amino acids 1–150, C1: amino acids 306–672 and C2:
amino acids 991–1165. Each construct was cloned into the pTriEX-4 vector (EMD
Biosciences) with fused S-tags and His-tags. Other fragments of human AC6 were constructed
and fused with GFP. These proteins are C1-306 (composed of amino acids 306–387 of AC6),
C1-388 (composed of amino acids 388–490 of AC6), C1-491 (composed of amino acids 491–
589 of AC6) and C1-590 (composed of amino acids 590–672 of AC6. Each construct was
cloned into the pEGFP vector (Invitrogen) with fused EGFP. All of the above constructs are
represented schematically in Figure 3. Transient transfections were performed using
Lipofectimine 2000 (Invitrogen) for 36–48 hr.
Triton X-100 insolubility
Cos-7 cells were grown to confluence in 35-mm dishes and extracted with 1 ml of lysis buffer
25 mM Mes, pH 6.5,0.15 M NaCl, 1% Triton X-100, 1 mM phenylmethylsulfonyl fluoride.
After 30 min on ice without agitation, the Triton-soluble extract was gently decanted, and the
Cell Signal. Author manuscript; available in PMC 2010 February 1.
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remaining Triton-insoluble material was solubilized in 1 ml of 1% SDS. This latter fraction,
termed the triton-insoluble extract, was homogenized by passing through a 26- gauge needle
ten times. Equal proportions of each fraction were separated by SDS-polyacrylamide gel
electrophoresis and analyzed by immunoblotting.
Non-detergent isolation of caveolar and non-caveolar membranes
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Transfected cells were fractionated using a detergent-free method described previously [28].
Two 10-cm plates containing 70 to 80% confluent Cos-7 or HEK-293 cells were washed twice
in ice-cold PBS and scraped into a total of 2 ml of 500 mM sodium carbonate, pH 11. Cells
were homogenized with a tissue grinder with three 10 sec bursts and then a sonicator with three
20 sec bursts. A full 1 min rest period was included in between each burst. 1 ml of homogenate
was brought to 45% sucrose by addition of an equal volume of 90% sucrose in MBS (25 mM
MES and 150 mM NaCl, pH 6.5) and loaded in an ultracentrifuge tube. A discontinuous sucrose
gradient was layered on top of the sample by placing 2 ml of 35% sucrose prepared in MBS
with 250 mM sodium carbonate then 1 ml of 5% sucrose (also in MBS/Na2CO3). The gradient
was centrifuged at 46,000 rpm on a SW55Ti rotor (Beckman Coulter, Fullerton, CA) for 16 to
18 h at 4°C. Fractions (10 × 0.5 ml) were collected from the top of the gradient, separated by
SDS-PAGE using proportional loading, and analyzed by immunoblotting. In some studies, the
faint light-scattering band was collected from the 5 to 35% sucrose interface (caveolin-enriched
membranes) while the bottom of the gradient (45% sucrose) was collected as noncaveolar
membranes.
Immunofluorescent confocal microscopy
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Intracellular localization of was visualized in living Cos-7 cells. Microscopy was performed
using a Zeiss LSM 410 confocal microscope equipped with a Krypton/Argon laser. EGFP
fluorescence was examined using a fluorescein isothiocyanate filter under a 40x oil immersion
lens. For each experimental condition, fluorescence distribution patterns similar to the images
shown were observed in the majority (~90%) of cells inspected. GFP-fusion protein expression
was determined by quantifying total fluorescence (excitation filter 475/20 nm, emission filter
515/30 nm), which was measured as relative fluorescence units (RFU). Upon addition of
coelenterazine total protein expression was determined by the light passed by the 450/58 filter,
and was measured in relative luciferase units (RLU). Cos-7 cells (1 × 105 cells) were plated
onto poly-L-lysine-coated glass coverslips and cultured for 24 h. Cells were then transfected
with 0.4 μg of cDNA using the Lipofectamine 2000 (Invitrogen). Cells were then washed with
phosphate-buffered saline (PBS; 12.1 mM Na2HPO4, 4 mM KH2PO4, and 130 mM NaCl, pH
7.4) and fixed using 4% paraformaldehyde (1 h, 20 °C). After fixing, cells were washed further
in PBS and permeabilized (1 h, 20 °C) with PBS containing 0.2% Triton X-100 and 1% goat
serum (blocking solution) and incubated (12 h, 20 °C) with anti-His TRITC conjugated
antibody or anti-caveolin-1 monoclonal antibody. After further washes in PBS (3 × 10 min),
cells were incubated (1 h, 20 °C) with Alexa Fluor 488 goat anti-mouse antibody. Coverslips
were mounted in Slowfade® light antifade (Molecular Probes) according to the manufacturer’s
procedures, and the cells were visualized on a Zeiss Axiovert LSM510 confocal microscope,
using a x63 oil immersion objective and a slice depth of 1 μm.
Immunoprecipitation
Transfected cells were lysed in buffer A (20 mM Tris, pH 8.0, 1% NP-40, 0.1% SDS, 140 mM
NaCl, 1 mM phenylmetanesulfonyl fluoride. For co-immunoprecipitation experiments, cell
lysates were incubated with anti-caveolin-1 monoclonal antibody for 1 hour at 4°C followed
by the addition of protein G agarose beads (Santa Cruz Biotechnology, CA) and further
incubated overnight at 4°C on a rocker platform. The resulting immunoprecipitates were
separated by centrifugation and both the precipitate and supernatant were collected for analysis.
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Immunoblot analysis
Whole cell lysates were obtained from COS-7 by scraping cells in modified RIPA lysis buffer
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Igepal CA-630, plus mammalian protease
inhibitor cocktail, Sigma cat# P-8340) and homogenizing by sonication. Equal protein amounts
of the lysates were separated by SDS-polyacrylamide gel electrophoresis (made) and
transferred to PVDF membranes (Millipore) by electroblotting. Membranes were blocked in
20mM phosphate buffered saline (PBS) with 3% nonfat dry milk and incubated with primary
antibody (see Materials) overnight at 4°C. Bound primary antibodies were visualized using
appropriate secondary antibody with conjugated horseradish peroxidase (Santa Cruz
Biotechnology) and ECL reagent (Pierce). In some experiments, proteins were detected using
an S-Tag-HRP detection kit (Novagen). Most primary antibodies recognized multiple nonspecific species. Only the band representing the appropriately sized immunoreactive band is
shown. The amount of protein per sample was determined using a dye-binding protein assay
(Bio-Rad).
Measurement of cAMP accumulation
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Cells plated at 80% confluency on 24-well plates were washed three times with serum and
NaHCO3-free DMEM supplemented with 20 mM HEPES, pH 7.4 (DMEH) and equilibrated
for 30 min. Assay for cAMP accumulation was performed by incubation with drugs of interest
plus 0.2 mM isobutylmethylxanthine, a PDE inhibitor, for 10 min. To terminate reactions,
assay medium was aspirated and 200μL lysis buffer (GE Healthcare) was added to each well.
cAMP content of the extract was quantified using the Biotrak EIA Kit (GE Healthcare) using
the manufacturer’s non-acetylation protocol. Data were normalized to the amount of protein
per sample, as determined using a dye-binding protein assay (Bio-Rad).

RESULTS
Expression of AC6 and caveolins in HEK-293 and COS-7cells

NIH-PA Author Manuscript

We first sought to characterize the native expression of AC6 in two cell types, COS-7 and
HEK-293 cells. We isolated buoyant lipid raft fractions from both these cell types using nondetergent fractionation followed by sucrose gradient centrifugation. COS-7 cells expressed
readily detectible levels of AC5 and AC6 (using an antibody that can not distinguish between
these two isoforms) almost exclusively in buoyant fractions also expressing caveolin-1 (Figure
1, top). These buoyant fractions were devoid of immunorectivity for either β-adaptin (a
clathrin-coated pit marker) or mannosidase II (a Golgi marker) while these proteins were
readily detectible in fractions 7 through 10 (data not shown). Transient transfection of the wildtype human AC6 led to increased AC5/6 immunoreactivity in these same buoyant fractions.
By contrast, HEK-293 cells express much lower levels of AC5/6 immunoreactivity, but the
detectible protein is also predominantly localized in the buoyant fractions (Figure 1, bottom).
The HEK-293 cell line used in our studies expresses little or no caveolin-1 or caveolin-2 (latter
data not shown). Transient transfection of human AC6 led to readily detectible AC5/6
immunoreactivity in buoyant fractions from HEK-293 cells. The non-raft protein adaptin-β, a
component of clathrin coated pits, is excluded from buoyant fractions in all experiments from
both cell types (data not shown). Thus, COS-7 and HEK-293 cells differ in their expression
levels of AC5/6 but the localization of AC6 in these two cells is consistent.
To more definitively understand the role of caveolins in the localization of AC6, we isolated
cardiac fibroblasts from wild-type and caveolin-1 knock-out mice. Mouse cardiac fibroblasts
(MCF) express AC2, AC3 and AC5/6 along with caveolin-1 (Figure 2). Caveolin-2 expression
Cell Signal. Author manuscript; available in PMC 2010 February 1.
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was not detected in MCF. AC3 and AC5/6 immunoreactivity was detected primarily in buoyant
lipid raft fractions that also contained caveolin-1 expression. By contrast, AC2 was detected
only in non-buoyant fractions, consistent with our previous findings from other cell types [1,
13]. Parallel studies of MCF isolated from caveolin-1 knockout mice yielded identical results
except for the fact that no caveolin-1 expression was detected (Figure 2, bottom). As with
studies of HEK-293 and COS-7 cells, β-adaptin and mannosidase II immunoreactivity were
detected exclusively in non-buoyant fractions (data not shown). Taken together, these data
imply that caveolin expression is not required for the lipid raft localization of AC6 or AC3.
Expression of intracellular domains of AC6
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A recent study by Crossthwaite et. al. showed that the transmembrane spanning domains were
not required for targeting AC5 to lipid rafts[26]. These investigators constructed chimeric AC’s
from raft (AC5) and non-raft (AC7) localized isoforms and found that the C1 and C2 domains
determined the lipid raft localization of AC5. Taking a different approach, we expressed
individual recombinant proteins corresponding to each of the three large cytosolic domains of
AC6 (N-terminus, C1 and C2 domains) to determine if they localized to lipid rafts (see
schematic representation of these protein constructs in Figure 3). Each protein was fused with
a His epitope and an S-protein tag for simplified isolation and detection. Confocal microscopy
confirmed that each protein is expressed largely in the cytosol, with only a minor proportion
of the C1 or C2 domains localized to the plasma membrane where the bulk of caveolin-1
staining was found (Figure 4). Thus, while expression of the individual cytosolic domains of
AC6 does not lead to a large percentage of expression in the plasma membrane, the approach
of expressing these individual domains was deemed useful for probing for the regions of AC6
responsible for its characteristic lipid raft localization.
Thus, we expressed each protein in COS-7 and HEK-293 cells and performed lipid raft
fractionation studies. Detection of the proteins via the fused S-protein tag revealed that while
the bulk of the expressed proteins were in the heavy fractions, as expected based upon their
appearance in cytosolic portions of the cell, only C1 and, to a slightly lesser extent, C2 could
be detected in the buoyant lipid raft fractions from either cell type (Figure 5). As in previous
studies, HEK-293 cells did not contain caveolin-1 immunoreactivity. As a complementary
approach, we used detergent-based solubilization of cells (1% Triton X-100) to determine the
association of the N-terminus, C1 and C2 domains with lipid rafts and also found that the C1
domain most readily associated with detergent-insoluble membranes (data not shown).
Expression of both C1 and C2 domains in the same cells did not alter the localization of either
construct in lipid rafts, indicating that there is limited or no cooperativity between these two
regions of AC6 (data not shown).
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We have previously shown that AC6 co-immunoprecipitates with caveolins [28]. Thus, we
immunoprecipitated caveolin-1 from plasma membrane fractions of COS-7 cells expressing
each of the three intracellular domains and probed for the S-tag fused to each construct. We
observed that virtually no N-terminal protein could be detected in caveolin-1 complexes,
indicating that this portion of AC6 did not associate with plasma membrane caveolin complexes
(Figure 6). However, virtually all the C1 protein and approximately half the C2 protein that
was present in plasma membranes from COS-7 cells was detected in caveolin-1
immunoprecipitated complexes. These data support the idea that the C1, and to a lesser extent
C2, form key interactions with caveolin-1 complexes.
To further dissect the regions of the C1 domain that may be responsible for the lipid raft
localization that we observed, we constructed four individual proteins of roughly equal size
that comprise the C1 domain of AC6 and fused each to GFP. These proteins are C1-306
(composed of amino acids 306–387 of AC6), C1-388 (composed of amino acids 388–490 of
AC6), C1-491 (composed of amino acids 491–589 of AC6) and C1-590 (composed of amino
Cell Signal. Author manuscript; available in PMC 2010 February 1.

Thangavel et al.

Page 7

NIH-PA Author Manuscript

acids 590–672 of AC6. These constructs are each represented schematically in Figure 3. We
expressed each of these C1 domain fragments into COS-7 cells and probed for their localization
in buoyant lipid raft fractions and their formation of immunprecipitable complexes with
caveolin-1. We found that only C1-306 and C1-388 partitioned to buoyant fractions from
sucrose gradient centrifugation (Figure 7, left panel). In addition, these same proteins were
detected in caveolin-1 immunoprecipitates while C1-491 and C1-561 were not (Figure 7, right
panel). Immunoprecipitation of each expressed C1 fragment was also performed, utilizing the
antibodies to the fused GFP. These studies confirm that caveolin-1 is readily detectible in
immunoprecipitated complexes with C1-306 and C1-388 and to a lesser extent C1-491, but
not with C1-561. These data are consistent with the idea that elements of the N-terminal half
of the C1 domain are responsible for lipid raft localization.
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Many proteins that localize in lipid rafts possess post-translational modifications, such as
palmitoylation, that drive their association with these lipid domains. Examination of the AC6
amino acid sequence reveals a putative palmitoylation site in the carboxy terminus at cysteine
1145[29]. Thus, we expressed epitope-tagged full length human AC6 and three different Cterminally truncated AC6 proteins. AC6-1127 is a protein truncated at Q1127, a total of 41
amino acids short of the wild-type AC6 and devoid of the C1145 residue that is the sole putative
palmitoylation site in the C-terminal region (see Figure 3). AC6-1144 is a protein truncated at
G1144, thus possesses the C1145 residue but would not be palmitoylated due to the lack of a
full palmitoylation motif (cys-aliphatic-aliphatic-any AA). AC6-1148 is a protein truncated at
V1148 and containing the full palmitoylation motif. We expressed each of these truncated AC6
proteins and wild-type AC6 in COS-7 cells and performed both lipid raft fractionations and
caveolin-1 immunoprecipitations to detect the localization of these recombinant proteins. Each
of these truncated protein retains full catalytic activity, as evidenced by the increase forskolinstimulated cAMP production following transfection of COS-7 cells with each construct (Figure
8c). Each of the truncated AC6 proteins localized to caveolin-rich, lipid raft fractions in a
manner indistinguishable from full length AC6 (Figure 8a). Furthermore, immunoreactivity
for each truncated protein was also readily detectible in caveolin-1 immunoprecipitates from
COS-7 cells (Figure 8b). Thus, deletion of the putative palmitoylation site in the C-terminal
tail of AC6 does not alter the characteristic lipid rat localization of this protein. These data re
consistent with the idea that none of the final 41 amino acids in the C-terminal play a critical
role in AC6 localization.

DISCUSSION

NIH-PA Author Manuscript

There has been growing appreciation in recent years that signaling proteins form complexes
with other key partners or can be compartmentized within the cell. Our lab and others have
demonstrated that AC’s have discreet localization properties within the plasma membrane of
mammalian cells and that this distinct localization can impart selective coupling between AC’s
and specific GPCR, allow tight regulation of downstream effectors by cAMP, or establish
highly efficient regulation of AC activity by other cellular signals [1,15,28,30]. One well
described AC isoform in regards to localization and function is AC6. This isoform is highly
enriched in lipid rafts of all mammalian cells in which it is expressed and forms complexes
with numerous other signaling molecules, including β-adrenergic receptors, caveolins and
other AC’s [11,12]. In this report, we describe data from our efforts to define how AC6 forms
protein–lipid and protein–protein interactions that allow the enzyme to partake in higher-order
signaling complexes and contribute to cAMP compartmentalization. We conclude that the
cytosolic C1 and C2 domains play a central role but that these domains do not appear to rely
upon known mechanisms for lipid raft localization. While much more information needs to be
gathered to fully understand the mechanisms of AC localization in lipid rafts, these data are
critical initial steps to unraveling the complex puzzle of GPCR-AC signaling.
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Three different, but perhaps complimentary, mechanisms have emerged that can cause the
localization of proteins in lipid rafts or caveolae. First, proteins can bind to caveolin oligomers
that form on the inner leaflet of lipid rafts to drive formation of caveolae [31]. Endothelial
nitric oxide synthase, insulin receptors, epidermal growth factor receptors are examples of
proteins that depend upon caveolin binding for their distinct localization. Second, proteins can
partition to lipid rafts via acylation, particularly palmitoylation or myristoylation of two or
more closely spaced residues[32,33]. Proteins such as caveolins, G proteins and certain
GPCR’s depend upon such post-translational modification to achieve their specific localization
[34,35]. Finally, there are sequence-dependant features of some transmembrane proteins that
drive interactions with lipid moieties to form “lipid shells” [36].
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None of these mechanisms for localizing proteins to lipid rafts and caveolae appear sufficient
to explain the distinct localization of AC6 to these lipid microdomains. As we report here, AC6
is localized to buoyant lipid raft fractions (as defined using sucrose density centrifugation) in
both cells that express caveolins and cells that lack caveolin expression (either naturally or via
knock-out, Figures 1 and 2). Thus, the caveolin binding hypothesis can’t explain AC6
localization. Crosthwaite et. al. recently reported that the chimeric substitution of the two 6
transmembrane spanning domains of AC5 (a lipid raft localized isoform) with those sequences
from AC7 (a non-raft localized isoform) did not alter the characteristic localization in lipid
rafts [26]. These data are inconsistent with the hypothesis transmembrane segments participate
in lipid shell formation to drive lipid raft localization of AC’s. Instead, other data from
Crossthwaite and coworkers implicate the intracellular segments of the enzyme as the elements
driving lipid raft localization. Our data confirm and extend these findings. By using reductionist
approaches (e.g. truncation, expression of individual intracellular domains) we show that the
C1 and C2 domains, but not the C-terminal 44 amino acids of C2 containing a putative
palmitoylation site, are critical for lipid raft localization of AC6.
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Several caveats of the reductionist approach we have utilized are evident. First, the individually
expressed cytosolic domains of AC6 do not have membrane targeting sequences or
hydrophobic transmembrane domains. Thus, expression of these bait proteins yields a sizable
proportion of protein that does not associate with membranes. This lack of targeting likely
limits the protein’s ability to find natural partners or form avid lipid associations. However,
the epitopes fused to each of these bait proteins allow sensitive detection via immunoblot and
thereby allow interpretable results despite a low abundance of bait protein finding its target.
Second, these individual proteins may not fully form their native tertiary structure since they
lack the rest of the complementary portions contained in the full length AC6. This lack of native
structure may limit their association with normal binding partners and reduce their native
localization. However, our data suggest that an appreciable proportion of the C1 domain, and
to a slightly lesser extent the C2 domain, do form associations that cause them to appear in
lipid raft fractions (Figures 5 and 6). Furthermore, the N-terminal half of the C1 domain appears
to contain sequences that confer this lipid raft localization, as evidenced by the partitioning of
C1-306 And C1-388 into lipid rafts (Figure 7). One may be tempted to interpret this data as
meaning several interactions are responsible for lipid raft association of AC6. However, more
studies are needed to determine the mechanisms for the observed localization.
The approaches used to characterize lipid rafts and caveolae can be fraught with
methodological pitfalls and carry high probability of experimental artifact. Cell fractionation
and sucrose density centrifugation destroys the cell architecture and has potential for
contamination of fractions with other cellular domains. Immunoprecipitation studies carry
significant probability that proteins form complexes after extraction, yielding false positives,
or that weaker protein-protein interactions are lost in the process, yielding false negatives. Light
microscopy is limited in resolution and falls short of being capable of defining a 50–100 nm
lipid raft. Electron microscopy depends upon reliable and specific antibodies and a high degree
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of epitope exposure in the protein of interest. Thus, no single method for defining lipid raft or
caveolar localization of a protein of interest is sufficient to reach reliable conclusions. In the
current studies, we performed immunoprecipitations, non-detergent cell fractionation with
sucrose density centrifugation and detergent-based extraction of membranes in an effort to
alleviate artifactual concerns. We also used fluorescent microscopy to confirm plasma
membrane association of our expressed proteins. Nonetheless, defining how (and in some cases
when) proteins associate with lipid rafts will require development of improved methods [32].
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GPCR-AC signaling is beginning to be understood in terms of internal intermolecular
associations, molecular dimerization and hetero-oligomerization with other signaling partners.
These conformations and associations likely influence the formation of the AC catalytic core,
regulate the trafficking of AC’s to the plasma membrane and dictate both the control of AC
activity by various signals and the physiological impact of the cAMP generated by the enzyme.
Complex formation of signaling molecules also allows rapid and specific signal transduction
and processing. The present findings make inroads to understanding the mechanism(s) driving
lipid raft localization of AC’s by focusing on smaller components of these large proteins that
are responsible. It is likely that these same forces are at work targeting many other
transmembrane signaling proteins, including receptors, cell adhesion molecules and others, to
lipid rafts and caveolae. Thus, characterizing these mechanisms are key to understanding how
signaling complexes form, how second messengers are compartmentized and how these aspects
of cellular signaling might be altered in pathophysiology.
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Figure 1. Endogenous and overexpressed AC6 are co-localized in lipid rafts independent of
caveolin-1 expression

Untreated COS-7 or HEK-293 cells (control) or cells incubated with an adenovirus expressing
human AC6 for 24 h (Adv-AC6) were fractionated using a non-detergent method to isolate
lipid rafts and caveolae (see Methods). Following sucrose density centrifugation, 10 fractions
were collected and fractions 2–10 were separated by SDS-PAGE and analyzed by immunoblot
using either anti-caveolin-1 or anti-his tag and S-protein. Images shown are representative of
4 experiments.

NIH-PA Author Manuscript
Cell Signal. Author manuscript; available in PMC 2010 February 1.

Thangavel et al.

Page 12

NIH-PA Author Manuscript
NIH-PA Author Manuscript

Figure 2. Endogenous AC3 and AC6 are localized in lipid rafts in cardiac fibroblasts from both
wild-type and caveolin-1 knock-out mice

Cardiac fibroblasts were isolated from wild-type and caveolin-1 knock-out mice and then
fractionated using a non-detergent method to isolate lipid rafts and caveolae (see Methods).
Following sucrose density centrifugation, 10 fractions were collected and fractions 2–10 were
separated by SDS-PAGE and analyzed by immunoblot using either anti-caveolin-1 or anti-his
tag and S-protein. Images shown are representative of 4–5 experiments.
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Figure 3. Schematic diagram of AC6 fragments and truncated proteins constructed for these studies
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Wild type (full length) AC6 is represented by the top bar, with each of the two cassettes of 6transmembrane domains represented by boxes for simplicity. Each bar below represents the
individual proteins constructed and expressed in this study, with their designation and various
epitope tags shown. The scale of these bars is representative only
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Figure 4. C1 and C2 domains, but not the N-terminus, of AC6 are partially associated with the
plasma membrane

COS-7 cells were transfected with each intracellular domain construct from AC6 then were
fixed in 2% paraformaldehyde, washed and permeablized (see Methods). Cells were then
incubated with an anti-His TRITC-conjugated antibody to detect the expressed proteins (red)
and a caveolin-1 monoclonal antibody (followed by Alexa Fluor 488 secondary antibody,
green) before being analyzed by confocal microscopy. Ab control (top, left) shows mocktransfected cell incubated with anti-His TRITC antibody. Images are representative of 3
experiments.
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Figure 5. The C1 domain of AC6 most strongly localizes in lipid raft/caveolar fractions

COS-7 or HEK-293 cells were transfected with each intracellular domain construct. Cells were
then fractionated using a non-detergent method to isolate lipid rafts and caveolae (see
Methods). Following sucrose density centrifugation, fractions were 2–4 were combined as the
Cav fraction and fractions 7–10 were combined as the non-cav fraction. Each pooled fraction
and a whole cell lysate control were separated by SDS-PAGE and analyzed by immunoblot
using an anti-His antibody to detect the expressed protein construct. Images shown are
representative of 4–5 experiments.
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Figure 6. The C1 and C2 domains are localized in Triton X-100 insoluble fractions and
immunoprecipitate with caveolin-1

COS-7 cells were transfected with each intracellular domain construct. Cells were then
separated into soluble and insoluble fractions in Triton-X 100 (left panels) or were lysed and
immunoprecipitation of caveolin-1 was performed (right panels, see Methods). Soluble and
insoluble fractions or caveolin-1 immunoprecipitates (IP) or supernatants (Sup) were separated
by SDS-PAGE and analyzed by S-Tag detection (to detect AC6 domain proteins) or
immunoblotting (to detect caveolin-1). Images shown are representative of 5 experiments.
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Figure 7. Segments in the N-terminal half of the C1 domain localize to lipid rafts and
immunoprecipitate with caveolin-1
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COS-7 cells were transfected with one of four proteins corresponding to a segment of the AC6
C1 domain. A: Cells were then fractionated using a non-detergent method to isolate lipid rafts
and caveolae, then fractions 2–10 were separated by SDS-PAGE and analyzed by immunoblot
using either anti-caveolin-1 (top image) or anti-GFP. B: Caveolin-1 (Cav-1) or GFP was
immunoprecipitated (IP, see Methods) and precipitates were immunoblotted (IB) for the
indicated protein. Images shown are representative of 3–5 experiments.
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Figure 8. Truncation of the C-terminal 41 amino acids of AC6 does not alter localization in lipid
rafts or cAMP production

COS-7 cells were transfected with either full length AC6 (wtAC6) or three different Cterminally truncated versions of AC6 (AC6-1127, AC6-1144 and AC6-1148). A: Cells were
fractionated using a non-detergent method to isolate lipid rafts and caveolae and the fractions
were separated by SDS-PAGE and expressed AC6 proteins detected by immunoblot for their
fused FLAG epitopes. B: Caveolin-1 was immunoprecipitated and precipitates (IP) and
supernatants (Sup) were separated by SDS-PAGE and expressed AC6 proteins detected by
immunoblot for their fused FLAG epitopes. Images shown are representative of 3–5
experiments (A and B). cAMP production was also measured in cells expressing wtAC6 or
truncated versions. Cells were incubated with (control) or without 10 μM forskolin for 10 min
and accumulated cAMP detected by EIA (see Methods). # denotes p > 0.05 by paired t-test as
compared to control. * denotes p > 0.05 by paired t-test as compared to vector only.
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